Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01874522
Recruitment Status : Completed
First Posted : June 11, 2013
Last Update Posted : December 23, 2015
Information provided by (Responsible Party):
Taiho Oncology, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : November 2015